CLSI I/LA28

Quality Assurance for Design Control and Implementation of Immunohistochemistry Assays, 2nd Edition

This document provides guidelines for the development of validated diagnostic, prognostic, and predictive immunohistochemical assays.

This reaffirmed document has been reviewed and confirmed as suitable to remain published without revision to content, as of September 2016. The document’s next scheduled review is generally five years after the reaffirmation date.

This document is available in electronic format only.

More Details

Member price:

List Price:

PDF Add to Cart

Details

Chairholder: Stephen M. Hewitt, MD, PhD and Max Robinowitz, MD

Date of Publication: January 31, 2011

Order Code PDF: CLSI ILA28A2E
ISBN Number: 1-56238-745-6

Order Code Print: print not available

Edition: Second

Pages: 152

CLSI I/LA28 Additional Details

If interested in ordering larger quantities of this document in print, please contact us here.

This document was formerly sold under the code MM04.

CLSI I/LA28 Abstract

I/LA28-A2 | Quality Assurance for Design Control and Implementation of Immunohistochemistry Assays, 2nd Edition This document provides guidelines for the development of validated diagnostic, prognostic, and predictive immunohistochemical assays. Chairholder: Stephen M. Hewitt, MD, PhD Organization: National Institutes of Health, National Cancer Institute Date of Publication: 01/31/2011 ISBN Number: 1-56238-745-6 Edition: Second Edition Pages: 152 Preview Sample Pages Nonmember Price: $140.00 Membership discount will be applied at checkout.